Literature DB >> 10671671

Expression of estrogen and progesterone receptors in carcinomas of the female breast in Tanzania.

M P Mbonde1, H Amir, R Schwartz-Albiez, L A Akslen, J N Kitinya.   

Abstract

In Africa breast cancer has been reported to occur frequently in young females and to show an aggressive histological and clinical picture, suggesting that this malignancy might have a different biology from this disease in Western females. To investigate this, the present study assessed by immunohistochemistry the expression of estrogen receptors (ER) and progesterone receptors (PgR) in 60 fresh frozen breast cancer tissues from indigenous Tanzanian patients. This prospective study collected tissues from routine patients treated at the Muhimbili Medical Center, Dar es Salaam, Tanzania. These markers have not been previously investigated in indigenous sub-Saharan females with breast cancer. Patients in this study expressed lower frequencies of ER (33%) and PgR (18%) as compared to literature reports including those about African-Americans. Expression of these markers, however, correlated with the demographic, clinical and histological characteristics in a similar way as observed elsewhere. A compounding effect of younger patients' age, advanced disease or late stage at hospital presentation and race in this geographical region could be responsible for the poor expression of hormonal receptors in the majority of patients as observed in this study. A surprising finding was that the proportion of hormonal receptor positive tumors increased with disease duration. In view of the low frequency of expression of hormonal markers, only 26.7% of the patients would be expected to benefit from hormonal therapy based on their expression of the hormone receptors. There is great need to undertake an inter-African study that would evaluate the hormonal status of more African women with breast cancer in different geographical regions of sub-Saharan Africa and document the true picture of their hormonal status. The outcome of these results could be important for treatment strategies for the second most common cancer among African women.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671671     DOI: 10.3892/or.7.2.277

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

1.  Breast cancer in Kumasi, Ghana.

Authors:  M Ohene-Yeboah; E Adjei
Journal:  Ghana Med J       Date:  2012-03

2.  The impact of neoadjuvant chemotherapy on patients with locally advanced breast cancer in a Nigerian semiurban teaching hospital: a single-center descriptive study.

Authors:  Olukayode Adeolu Arowolo; Andrew Akinbolaji Akinkuolie; Oladejo Olukayode Lawal; Olusegun Isaac Alatise; Abdulkadir Ayo Salako; Adewale Oluseye Adisa
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

3.  Clinical and epidemiologic profile of breast cancer in Tanzania.

Authors:  Ashley M Burson; Amr S Soliman; Twalib A Ngoma; Julius Mwaiselage; P Ogweyo; Mohab S Eissa; Subhojit Dey; Sofia D Merajver
Journal:  Breast Dis       Date:  2010

4.  Breast cancer burden in central Sudan.

Authors:  Elgaili M Elgaili; Dafalla O Abuidris; Munazzah Rahman; Arthur M Michalek; Sulma I Mohammed
Journal:  Int J Womens Health       Date:  2010-08-09

5.  Invasive breast Cancer treatment in Tanzania: landscape assessment to prepare for implementation of standardized treatment guidelines.

Authors:  Rupali Sood; Nestory Masalu; Roisin M Connolly; Christina A Chao; Lucas Faustine; Cosmas Mbulwa; Benjamin O Anderson; Anne F Rositch
Journal:  BMC Cancer       Date:  2021-05-10       Impact factor: 4.430

6.  Evaluating Estrogen Receptor Immunohistochemistry on Cell Blocks From Breast Cancer Patients in a Low-Resource Setting.

Authors:  Asteria H Kimambo; Edda A Vuhahula; Amos R Mwakigonja; Britt-Marie Ljung; Li Zhang; Katherine Van Loon; Dianna L Ng
Journal:  Arch Pathol Lab Med       Date:  2021-07-01       Impact factor: 5.686

7.  Systematic review of breast cancer biology in developing countries (part 1): Africa, the middle East, eastern europe, Mexico, the Caribbean and South america.

Authors:  Riyaz Bhikoo; Sanket Srinivasa; Tzu-Chieh Yu; David Moss; Andrew G Hill
Journal:  Cancers (Basel)       Date:  2011-05-13       Impact factor: 6.639

8.  Difference in Risk Factors for Breast Cancer by ER Status in an Indigenous African Population.

Authors:  M Galukande; H Wabinga; F Mirembe; C Karamagi; A Asea
Journal:  ISRN Oncol       Date:  2013-06-25

9.  Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients.

Authors:  Peter Rambau; Nestory Masalu; Kahima Jackson; Philipo Chalya; Patrizia Serra; Sara Bravaccini
Journal:  BMC Res Notes       Date:  2014-06-26

10.  Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population.

Authors:  Moses Galukande; Henry Wabinga; Florence Mirembe; Charles Karamagi; Alexzander Asea
Journal:  Pan Afr Med J       Date:  2014-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.